CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 7, 2005--POZEN Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will be
speaking to investors at NCINVEST2005 on Wednesday, February 16, 2005
at 10:15 a.m. Eastern Time at the Friday Center in Chapel Hill, North
Carolina. Dr. Plachetka's presentation will be webcast and archived on
POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN is
also exploring the development of product candidates in other
pain-related therapeutic areas. POZEN has development and commercial
alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN, Inc.
Bill Hodges 919-913-1030
Chief Financial Officer
Fran Barsky 919-913-1044
Director, Investor Relations
SOURCE: POZEN, Inc.